Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea currently has about 150 employees and is listed on the SIX Swiss Exchange (SIX: BSLN). Please visit basilea.com.
Company Details
- Employees
- 233
- Founded
- -
- Address
- Hegenheimermattweg 167b, Allschwil,basel-Country 4123,switzerland
- Phone
- 41616061112
- in****@****lea.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- basilea.com
- Keywords
- Pharmaceuticals, Biopharma, MRSA.
- HQ
- Allschwil, Basel-Country
Basilea Pharmaceutica Questions
Basilea Pharmaceutica's helpline number is 41616061112
Basilea Pharmaceutica's website is basilea.com
Basilea Pharmaceutica's LinkedIn profile is https://ch.linkedin.com/company/basilea-pharmaceutica-ltd
Basilea Pharmaceutica has
233 employees.
View email and phone details for 233
employees at Basilea Pharmaceutica.
Basilea Pharmaceutica's industry is
Biotechnology Research
Basilea Pharmaceutica's top competitors are
Santhera Pharmaceuticals,
Bachem,
Moonlake Immunotherapeutics (Nasdaq: Mltx),
Idorsia Pharmaceuticals Ltd,
Solvias,
Actelion (Now Janssen Pulmonary Hypertension),
Roche,
Alentis Therapeutics,
Tillotts Pharma Ag,
Lonza.
Basilea Pharmaceutica's support email address is info_basilea@basilea.com
Basilea Pharmaceutica's categories are Biotechnology Research
Basilea Pharmaceutica's founding year is 2000
